Literature DB >> 9232759

Re-using data from case-control studies.

A J Lee1, L McMurchy, A J Scott.   

Abstract

Despite its ability to maximize statistical power while keeping data collection costs to a minimum, case-control sampling provides a non-representative sample of the population. When fitting a logistic regression model to data obtained in such a study, using the variable stratifying the population as the response, it is well known that the estimate of the constant term will be biased, but those of the coefficients of the covariates will not. However, subsequent to the case-control study, it is often desired to conduct a secondary analysis, using a variable that was previously a covariate in the main study as the response. If this new response is associated with the original variable used to stratify the population into cases and controls, a conventional logistic regression analysis will usually result in biased estimates of all the regression coefficients, not just the constant. This situation has recently been studied by Nagelkerke et al. who describe some situations where no bias occurs. In this paper we discuss how to calculate maximum likelihood estimates of all the regression coefficients, in the situation where the sampling rates for cases and controls are known. An example using data from the New Zealand Cot Death Study is presented.

Mesh:

Year:  1997        PMID: 9232759     DOI: 10.1002/(sici)1097-0258(19970630)16:12<1377::aid-sim557>3.0.co;2-k

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  18 in total

1.  A general regression framework for a secondary outcome in case-control studies.

Authors:  Eric J Tchetgen Tchetgen
Journal:  Biostatistics       Date:  2013-10-22       Impact factor: 5.899

2.  Unified Analysis of Secondary Traits in Case-Control Association Studies.

Authors:  Arpita Ghosh; Fred A Wright; Fei Zou
Journal:  J Am Stat Assoc       Date:  2013       Impact factor: 5.033

3.  A Gaussian copula approach for the analysis of secondary phenotypes in case-control genetic association studies.

Authors:  Jing He; Hongzhe Li; Andrew C Edmondson; Daniel J Rader; Mingyao Li
Journal:  Biostatistics       Date:  2011-09-19       Impact factor: 5.899

4.  A Robust and Powerful Set-Valued Approach to Rare Variant Association Analyses of Secondary Traits in Case-Control Sequencing Studies.

Authors:  Guolian Kang; Wenjian Bi; Hang Zhang; Stanley Pounds; Cheng Cheng; Sanjay Shete; Fei Zou; Yanlong Zhao; Ji-Feng Zhang; Weihua Yue
Journal:  Genetics       Date:  2016-12-30       Impact factor: 4.562

5.  Higher biomarker-calibrated protein intake is not associated with impaired renal function in postmenopausal women.

Authors:  Jeannette M Beasley; Aaron K Aragaki; Andrea Z LaCroix; Marian L Neuhouser; Lesley F Tinker; Jane A Cauley; Kristine E Ensrud; Rebecca D Jackson; Ross L Prentice
Journal:  J Nutr       Date:  2011-06-08       Impact factor: 4.798

6.  Regression analysis for secondary response variable in a case-cohort study.

Authors:  Yinghao Pan; Jianwen Cai; Sangmi Kim; Haibo Zhou
Journal:  Biometrics       Date:  2017-12-29       Impact factor: 2.571

7.  Secondary outcome analysis for data from an outcome-dependent sampling design.

Authors:  Yinghao Pan; Jianwen Cai; Matthew P Longnecker; Haibo Zhou
Journal:  Stat Med       Date:  2018-04-22       Impact factor: 2.373

8.  Outcome-dependent sampling for longitudinal binary response data based on a time-varying auxiliary variable.

Authors:  Jonathan S Schildcrout; Sunni L Mumford; Zhen Chen; Patrick J Heagerty; Paul J Rathouz
Journal:  Stat Med       Date:  2011-11-16       Impact factor: 2.373

9.  Analysis of secondary phenotypes in multigroup association studies.

Authors:  Fan Zhou; Haibo Zhou; Tengfei Li; Hongtu Zhu
Journal:  Biometrics       Date:  2019-11-11       Impact factor: 2.571

10.  Bias correction to secondary trait analysis with case-control design.

Authors:  Hua Yun Chen; Rick Kittles; Wei Zhang
Journal:  Stat Med       Date:  2012-09-17       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.